Site news

LSST’s Deputy CEO applauds Nestlé’s value-added attention to peanut allergies

 
Picture of Connect Admin
LSST’s Deputy CEO applauds Nestlé’s value-added attention to peanut allergies
by Connect Admin - Monday, 21 September 2020, 12:53 PM
 

LSST’s Deputy CEO, Mr Mohammed Zaidi, has trumpeted Nestlé’s totemic attention to peanut allergy prevention and for adjoining vision-to-value as it acquires Aimmune Therapeutics, the maker of pioneering peanut allergy treatments, in a $2.6 billion deal. More details